CRNX
Companies
NASDAQ
Crinetics Pharmaceuticals Inc.
Health Care
$29.91
-$20.19 (-39.49%)
Price Chart
Overview
About CRNX
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Market Cap
$3.5B
Volume
28.5M
Avg. Volume
28.8M
P/E Ratio
-8.093265
Dividend Yield
0.00%
Employees
202.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.22
Moderate Correlation
Volatility
High (0.56)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CRNX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$3.5B
Volume28.5M
P/E Ratio-8.09
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025